A record of what Centrum Broking Analysis said publicly, with the source. Not advice.
“Centrum Broking maintains a 'BUY' rating on Colgate-Palmolive (India) with a revised DCF-based target of Rs 3,215 (implied 47.8x FY27E EPS). Growth is expected from category development, product diversification beyond oral care, increased consumption frequency, and deeper rural penetration. They anticipate gradual urban demand recovery and strong rural recovery, leading to volume-led growth and stable margins despite higher ad spends. Risks include rural demand weakness and rising inflation.”
Centrum Broking Analysis’s track record (trackable calls only): 19 graded calls · 95% CI 23–64%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹3,215, as stated.
Window: 12 months, the default when no time frame is stated.
Neither the target ₹3,215 was reached on a close by the end of the window. Miss.
The grader’s working: R4 TARGET_CALL: entered ₹2763.5 on 2025-02-03 (next trading session's close); neither target nor stop reached by window end 2026-02-01. Window 365 days — rule H3: a target call whose quote states no time frame is given 12 months, the broker convention.